Navigation Links
Octapharma Grants Program Awards First Research Grant to Rush University Medical Center
Date:8/2/2010

n suggested by some; in particular, discontinuing prophylaxis after a boy reaches skeletal maturity. The rationale offered is that the impact of hemarthrosis on mature joints is less deleterious than on those of younger patients.

"We expect that the data will not support the hypothesis that bleeding into the mature joint is less detrimental compared to hemarthrosis in the younger skeletally immature joint," said Dr. Valentino. "This data will indicate that prophylaxis should be continued in adults."

To test the hypothesis that older, skeletally mature joints are less susceptible to blood-induced joint damage, mice deficient in factor 8 gene expression will be studied. Animals at different ages will be subjected to a single massive experimental hemarthrosis and then sacrificed in the month after the joint bleeding to assess the severity of hemophilic arthropathy. The diameter of the affected knee joints of immature and mature mice will be compared. The joints will then be isolated and subjected to histological and image analysis using micro-computed tomography.

The Octapharma Grants Committee is currently reviewing the first cycle of 2010 grant applications and recipients will be announced following the analysis. The deadline for the next cycle of 2010 submissions will be September 31. Please visit www.octapharmagrants.com for a complete description of the grants program.

About the Octapharma Group

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein products
'/>"/>

SOURCE Octapharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Octapharma Aims to Expand U.S. Immune Globulin Therapy Portfolio
2. Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations
3. Octapharma USA Retains Yankee Public Relations as its Agency of Record
4. MultiCell Technologies Applies for Qualifying Therapeutic Discovery Project Grants
5. Life Sciences Discovery Fund announces commercialization grants
6. Sirnaomics Receives Two SBIR Grants from NIH for Developing siRNA Therapeutics to Treat Glioblastoma and Influenza Infection
7. Progenika Biopharma Grants Grifols World-Wide Distribution Rights for the BLOODCHIP® Genotyping Test for Blood Donors
8. Details Issued Today on $1 Billion in Biotech Tax Credits and Grants
9. Gary and Mary West Foundation Grants $20 Million to Advance Engineering Efforts Within the West Wireless Heath Institute
10. Zimmer Holdings Announces 2010 Funding for OMeGA Medical Grants Association
11. FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 28, 2014 Whitehouse Laboratories is ... term partnership with PTI Inspection Systems that ... state of the art leak testing method development and ... instruments currently available. As part of this agreement, Whitehouse ... Voltage Leak Detection Instrument developed and manufactured by ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Green & ... in Series B funding and secured Otter Capital as ... capital will accelerate commercialization of GGI’s Agriplier™ technology, building ... types. , “Since our first meeting, we have ... the biological product space,” said Alan Sobba, President and ...
(Date:8/27/2014)... August 27, 2014 In 2013, ... Lawrence Livermore National Security LLC (LLNS), ... and deliver a state-of-the-art laser system for the ... Beamlines), under construction in the Czech Republic. , ... laser system, called the " High repetition-rate Advanced ...
(Date:8/27/2014)... 27, 2014   MSC , a healthcare performance ... announced the appointment of Mary Beth Loesch ... years of experience preparing companies for rapid growth and ... Vice President of Corporate Development and Healthcare. In that ... , as well as corporate strategy and marketing. Previously, ...
Breaking Biology Technology:Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3MSC names Mary Beth Loesch President and CEO 2
... Driven by the human genome project, and research in the ... antibacterial, antifungal, and genetic therapeutics), world market for biotechnology reagents ... towards proteomics from genomics in the post-genome-project research period is ... years. , ...
... Nov. 12 Melbourne-based Starfish,Ventures announced today the ... $185 million, the largest venture capital fundraising in,Australia. ... and Cleantech,companies., The success of this fundraising ... of Australia,s ability to foster the development of,innovative ...
... Nov. 12 TorreyPines Therapeutics,Inc. (Nasdaq: TPTX ) ... Graham as the Company,s Chief Executive Officer and as ... had been serving as,the Company,s acting Chief Executive Officer ... impressive job as acting CEO in managing the transition,of ...
Cached Biology Technology:World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc. 2World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc. 3Starfish Ventures Closes Australia's Largest Venture Capital Fund With $185 Million Tech Fund 2TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors 2TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors 3
(Date:8/28/2014)... 28, 2014  Privacy Advocate and Senior Staff Attorney ... , joins the lineup of biometric and mobile commerce ... UnPlugged Executive Summit in Tampa, Florida ... announced speakers include Steven Rahman, Director, Technology and Strategy at ... Experian. The theme of this year,s event is Mobility ...
(Date:8/28/2014)... 28, 2014A new method for measuring and imaging how ... and researchers better understand how drug abuse affects the ... tissue engineering, and lead to better treatment options for ... team of researchers from Stony Brook University in New ... was published today in The Optical Society,s (OSA) open-access ...
(Date:8/28/2014)... significant health risk to people with asthma according to a ... Clinical Immunology . , By critically reviewing the findings from ... that the presence of several types of mould can lead ... the likelihood of developing the condition. , The research has ... Medical School and is the first time all of the ...
Breaking Biology News(10 mins):Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3Indoor mold poses health risk to asthma sufferers 2
... Missouri-Columbia has discovered a way to create engineered minichromosomes ... discovery opens new possibilities for the development of crops ... and herbicides, and for the development of proteins and ... , In a paper published in the Proceedings of ...
... In the daunting marathon that leads to successful ... before entering clinical trials. Researchers from Massachusetts Institute ... cell culture test for assessing a compound's genetic ... animal tests. This assay would allow genetic toxicity ...
... to rapid genetic adaptations in the nematode Acrobeloides ... and lay more eggs under polluted conditions than ... Doroszuk demonstrated this in her study into the ... , Environmental pollution is an important cause ...
Cached Biology News:Researchers attach genes to minichromosomes in maize 2DNA-damage test could aid drug development 2DNA-damage test could aid drug development 3Asexual worm quickly adapts to soil contamination 2
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
Request Info...
... are available in two product models - the ... models is that the 6000AT+ includes a membrane ... aerosol for improved detection limits and reduced oxides. ... range of elements by 10-40 times. Note that ...
... available in two product models - the 5000AT+ ... is that the 6000AT+ includes a membrane desolvation ... for improved detection limits and reduced oxides. The ... of elements by 10-40 times. Note that with ...
Biology Products: